ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results Portfolio News / By Karina Tin May 20, 2020 ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results Read More »
RAPT Therapeutics Reports First Quarter 2020 Financial Results Portfolio News / By Karina Tin May 14, 2020 RAPT Therapeutics Reports First Quarter 2020 Financial Results Read More »
Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress Portfolio News / By Karina Tin May 14, 2020 Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress Read More »
Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610 in Three EHA Abstracts Portfolio News / By Karina Tin May 14, 2020 Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610 in Three EHA Abstracts Read More »
NGM Bio Provides Business Update and Reports First Quarter 2020 Financial Results Portfolio News / By Karina Tin May 13, 2020 NGM Bio Provides Business Update and Reports First Quarter 2020 Financial Results Read More »
Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights Portfolio News / By Karina Tin May 7, 2020 Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights Read More »
Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results Portfolio News / By Karina Tin May 6, 2020 Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results Read More »
Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates Portfolio News / By Karina Tin May 5, 2020 Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates Read More »
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Portfolio News / By Karina Tin April 28, 2020 ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Read More »
Ribon Therapeutics Presents Preclinical Data from its PARP7 and PARP14 Programs at AACR Virtual Meeting I Portfolio News / By Karina Tin April 27, 2020 Ribon Therapeutics Presents Preclinical Data from its PARP7 and PARP14 Programs at AACR Virtual Meeting I Read More »